PMGC Holdings (ELAB) Inventory (2022 - 2026)

PMGC Holdings (ELAB) posted Inventory of $253558.0 for Q1 2026, up 166.63% sequentially from $95098.0 in Q4 2025.

PMGC Holdings (ELAB) Inventory (2022 - 2026) Analysis & Trends

PMGC Holdings has reported Inventory for 5 years, with the latest figure at $253558.0 in Q1 2026.

Quarterly Inventory changed N/A year-over-year to $253558.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $253558.0 (changed N/A YoY) and the FY2025 annual result came in at $95098.0, changed N/A from the prior year.
Inventory advanced to $253558.0 in Q1 2026 per ELAB's latest filing, from $95098.0 in the prior quarter.
Over five years, Inventory peaked at $499.3 million in Q3 2023 and troughed at $95098.0 in Q4 2025.
A 5-year average of $55.9 million and a median of $495667.0 in 2023 frame the typical range for Inventory.
The sharpest annual moves came in 2023 and 2024: Inventory jumped 115.37% in 2023, then slumped 99.8% in 2024.
Over 5 years, Inventory stood at $230145.0 in 2022, then surged by 115.37% to $495667.0 in 2023, then jumped by 99.01% to $986421.0 in 2024, then sank by 90.36% to $95098.0 in 2025, then jumped by 166.63% to $253558.0 in 2026.
According to Business Quant data, Inventory over the past three periods registered $253558.0, $95098.0, and $128469.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	1.77 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	3.08 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	371.00 Mn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	280.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	732.60 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	97.11 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	142.38 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	128.86 Mn
10	PMGC Holdings	3.01 Mn	-15.78 Mn	385,691.00	932,508.00

Download Data